Resultados de la búsqueda 581-590 of 1029 for Alternative

  1. Oncología (médica) - Ensayos clínicos

    This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

  2. Oncología (médica) - Ensayos clínicos

    This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...

  3. Oncología (médica) - Ensayos clínicos

    This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has ...

  4. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to culture human mammary cells to identify cellular characteristics associated with lobular involution status. Cutaneous Lymphoma ...

  5. Oncología (médica) - Ensayos clínicos

    Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to bring molecular risk prediction for breast cancer into the clinical arena through: the ...

  6. Oncología (médica) - Ensayos clínicos

    This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this combination ...

  7. Oncología (médica) - Ensayos clínicos

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Effective treatments for recurrent gynecological cancer are lacking, and there is a need for novel therapeutic options. One of the barriers to improving ...

  9. Oncología (médica) - Ensayos clínicos

    The purpose of this research trail is to study the genetic alteration/mutation and immune profiling in surgical resected Non-small Cell Lung Cancer (NSCLC) ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients' tumors will be sequenced during a pre-registration component or will have had successful sequencing pre-study. A personalized neoantigen peptide ...